GLP-1 Benefits Are Growing Fast: The Follow-Up Problem Nobody Talks About
By

GLP-1 medications and hormone therapies have moved from niche to mainstream. About 19% of large employers now cover GLP-1 drugs used primarily for weight loss, according to the Kaiser Family Foundation’s Employer Health Benefits Survey. That figure climbs to 43% among employers with 5,000 or more workers. What wasn’t always part of that design was the clinical infrastructure to support ongoing use.
Now, new research shows where that coverage stops – and what that gap is costing employers.
GLP-1 and Hormone Coverage: Where It Stops
Maven Clinic’s Beyond the Script report surveyed 1,538 women and 520 healthcare providers across the U.S. Thirty-seven percent of women who used medications for weight, metabolism or hormones said follow-up care felt limited, inconsistent or didn’t exist at all. Providers describe similar problems from their side. Forty-one percent said they don’t have enough visit time to support patients after prescribing GLP-1 medications, and nearly half reported uncertainty about when GLP-1s are clinically appropriate in the first place.
Prescription coverage without clinical follow-through carries a price, one that accumulates in claims costs, productivity and retention before most HR teams have a way to measure it.
The Coordination Cost HR Isn’t Measuring
The reality is, GLP-1s and hormone therapies aren’t one-and-done treatments. They interact with reproductive history, hormonal health, mental health and metabolic function in ways that shift over time. Managing them well requires continuity on top of initial access.
The Maven research provides specifics: Only 19% of women say their hormones are always considered in their reproductive care. More than half suspected their symptoms were connected and were told they weren’t. When healthcare is delivered piecemeal, employees have to pick up the coordination: scheduling appointments, tracking their own health data and moving records between providers who don’t share systems. These healthcare-related tasks pull employees away from the workday in ways that don’t show up in absence records.
Maven’s outcomes data reveals what changes when healthcare is better connected: 60% of Maven members report being more productive at work after getting access to coordinated care. It’s a productivity return that most benefits packages aren’t designed to track.
What Connected Healthcare Can Deliver for Employers
Maven Clinic recently launched a direct-to-consumer platform connecting GLP-1 and hormone care with broader women’s health services across 30-plus specialties. The platform is built on the premise that women’s health conditions don’t exist in isolation.
“What women are experiencing is not a series of isolated issues,” said Dr. Janelle Duah, Maven Clinic’s Associate Medical Director. “Hormonal and metabolic health impacts sleep, cardiovascular health, mental health, reproductive health, and overall quality of life.”
The outcomes are measurable for employers already partnering with Maven. In Maven’s client population, members save $9,600 per birth on average, NICU admission rates are 27% lower and a Fortune 25 client saw $5,500 in per-member healthcare savings with a 14% reduction in total cost of care.
For HR and finance leaders, those figures represent the business case for connected healthcare: the difference between funding a benefit and managing the cost over time. Adding GLP-1 or hormone coverage without a clinical support structure is an expense without a strategy.
Questions to Bring to Your Next Benefits Review
For many HR teams, open enrollment planning is just around the corner, and the cost picture makes this year’s review more consequential than most. Healthcare costs are rising 8.4% annually, with women’s and family health driving an outsized share of those increases. Analysis from Blue Cross Blue Shield projects broad GLP-1 coverage could raise employer premiums by as much as 14%. Employers who added GLP-1 and hormone coverage made an important coverage decision.
The question now is whether the benefits package is built to support those therapies over time. As you’re preparing for open enrollment or vendor reviews, here are the questions to bring to the conversation:
- How is clinical follow-up for GLP-1 users structured in your plan, and which vendor is accountable for outcomes?
- Are hormone and metabolic health managed together in your benefits package or split across separate vendors?
- When an employee has overlapping hormonal, metabolic and reproductive health needs, does your benefits package include a provider that can address them together?
Employers that added GLP-1 and hormone coverage early are ahead on access. The next step is building a benefits structure that makes the coverage work.
Further Reading
Connecticut Paid Sick Leave Expands to Nearly All Employers Jan. 1
Starting Jan. 1, 2027, employers with one or more employees in Connecticut must provide paid sick leave under Public Act 24-8. The current threshold for covered employers is 11 or more employees. Covered employers must allow covered employees to accrue one hour of paid leave for every 30 hours worked, up to 40 hours a […]
Paid Sick Leave Notice Failures: Seattle Hotel, Staffing Agencies Pay $133K
A Seattle hotel operator and two staffing agencies will pay $133,026 to 11 workers to resolve alleged violations of the city’s paid sick leave ordinance and two other local laws protecting hotel employees. Investigators found evidence the companies: Payroll teams should check that pay stubs or other paid sick leave notices show leave earned, used […]
Colorado Cuts FAMLI Premium Rate to 0.86% for 2027
Colorado’s Family and Medical Leave Insurance (FAMLI) premium rate will decrease from 0.88% to 0.86% of wages effective Jan. 1, 2027. The new rate applies to all employers using the state plan. Employers should update payroll settings before their first 2027 pay run, according to the state’s FAMLI Business Brief. Employees may pay no more […]
IRS Raises 2027 Retirement Contribution Limits for 401(k)
The IRS has announced that the 2027 contribution limit for 401(k), 403(b) and 457(b) retirement plans will increase to $25,500, up from $24,500 in 2026. Higher Catch-Up Limits Boost Retirement Savings Catch-up limits are going up, too: The higher catch-up replaces the standard one, so employees can’t stack the two. And employees can make catch-up […]
Paid Parental Leave: New Requirements for Allegheny County Employers
On Oct. 22, 2026, Allegheny County, Pa., enacted what’s believed to be the nation’s first countywide paid parental leave mandate. Employers must comply by October 2027. Employers doing business in the county with 15 or more employees anywhere must fund 12 weeks at base pay, capped at $4,200 weekly, for birth, adoption, child placement or […]
Washington Paid Leave Premium Increases Jan. 1
On Jan. 1, 2027, Washington’s Paid Family & Medical Leave premium increases to 1.2%, from 1.13%. Employers will pay 29.3% of the paid leave premium; the employee share is 70.7%. Employers may cover some or all of employees’ share. Generally, employers with fewer than 50 employees don’t need to pay the employer share unless they […]